TennesseeTennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 10Assigned to General Subcommittee of Senate Commerce and Labor CommitteeLatest
- Mar 5Passed on Second Consideration, refer to Senate Commerce and Labor CommitteeMinor
- Mar 4Placed on Senate Commerce and Labor Committee calendar for 3/10/2026
- Mar 2Approved by Delayed Bills Committee
- Mar 2Introduced, Passed on First ConsiderationMinor
- Feb 2Filed for introductionMinor
- Feb 2Refer to Senate Delayed Bills CommitteeIntroduced